ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.759,51
-0,01%
S&P 500
5.360,79
0,26%
US Dollar vs BRL
5,3541
0,00%
Bitcoin
67.859,13
-2,37%
Brent Oil
81,375
-0,49%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Catalyst Biosciences Inc (CBIO)

  7. Catalyst Biosciences Inc (CBIO) Notícias

CBIO

Catalyst Biosciences (CBIO)

Catalyst Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CBIO
DataHoraFonteTítuloCódigoCompanhia
02/05/202419:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
01/05/202417:51Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
29/04/202409:49Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:CBIOCatalyst Biosciences Inc
29/04/202409:48Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CBIOCatalyst Biosciences Inc
29/04/202409:46Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CBIOCatalyst Biosciences Inc
19/04/202417:06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CBIOCatalyst Biosciences Inc
26/03/202418:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CBIOCatalyst Biosciences Inc
21/03/202421:27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
24/01/202419:11Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
19/01/202418:05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
29/11/202318:01Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:CBIOCatalyst Biosciences Inc
22/11/202321:06Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
13/11/202319:13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:CBIOCatalyst Biosciences Inc
30/10/202313:00GlobeNewswire Inc.Catalyst Biosciences Announces Completion of Business Combination With Beijing Continent Pharmaceuticals and Implementation of Name Change and Reverse Stock SplitNASDAQ:CBIOCatalyst Biosciences Inc
30/10/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CBIOCatalyst Biosciences Inc
27/10/202318:10Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CBIOCatalyst Biosciences Inc
26/10/202318:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CBIOCatalyst Biosciences Inc
24/10/202317:08Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
24/07/202317:40Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CBIOCatalyst Biosciences Inc
20/07/202309:57Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:CBIOCatalyst Biosciences Inc
12/07/202317:30Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:CBIOCatalyst Biosciences Inc
26/06/202317:07Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBIOCatalyst Biosciences Inc
20/06/202318:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBIOCatalyst Biosciences Inc
30/03/202317:14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBIOCatalyst Biosciences Inc
28/02/202313:45AllPennyStocks.comBiotech Soars On Asset Purchase AgreementNASDAQ:CBIOCatalyst Biosciences Inc
28/02/202310:00GlobeNewswire Inc.Catalyst Biosciences Provides Corporate UpdateNASDAQ:CBIOCatalyst Biosciences Inc
13/02/202316:56Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CBIOCatalyst Biosciences Inc
05/01/202318:07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CBIOCatalyst Biosciences Inc
05/01/202308:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBIOCatalyst Biosciences Inc
27/12/202209:00GlobeNewswire Inc.Catalyst Biosciences Completes First Steps in Reverse Merger PlanNASDAQ:CBIOCatalyst Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CBIO

Seu Histórico Recente

BIT
UC5T11
Unicredit Bank
BIT
P1SOY4
BNP Paribas Issuance
LBNK
MARSRISEUSDT
MarsRise
EU
N384S
N384S
TSXV
SSSS.P
Shooting Star Acquisition
LSE
AG77
Br.tel. 27
BIT
P1Q769
BNP Paribas Issuance
ASX
RCB
Russell Investments
BMF
DIFV24N26
DIFV24N26 - 10/2024
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados